mk-0616
merck
[]
breaking: oral pcsk-9 inhibitor is effective with 60% ldl lowering without important side effects in a short 8 weeks fase 2 study
#acc23 #pcsk9 #mk0616 #oral #latebreaking #trial 
Consultant Internal Medicine | Specialized Vascular Medicine |Chairman Department of Internal Medicine @OLVG  | I see | study | stimulate |
Ook @dokterinpodcast